Sandbox:patho2: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 10: Line 10:
:* Nerve tissues in the neck (1-5% of the cases)  
:* Nerve tissues in the neck (1-5% of the cases)  
:* Nerve tissues in the pelvis (2-3% of the cases)
:* Nerve tissues in the pelvis (2-3% of the cases)
* Neuroblastoma cells can secrete catecholamines such as:
* Neuroblastoma tumor cells secrete catecholamines such as:
:* Vanillylmandelic acid (VMA)
:* Vanillylmandelic acid (VMA)
:* Homovanillic acid (HVA)
:* Homovanillic acid (HVA)
Line 43: Line 43:


==Microscopic Pathology==
==Microscopic Pathology==
* On microscopic histopathological analysis the presence of round blue cells separated by thin fibrous septa are characteristic findings of neuroblastoma.
* On microscopic histopathological analysis the presence of round blue cells separated by thin fibrous septa are characteristic findings of neuroblastoma.
* Other findings of neuroblastoma on microscopic pathology may include:
* Other findings of neuroblastoma on light microscopy may include:
:* Homer-Wright rosettes (rosettes with a small  meshwork of fibers at the center)
:* Homer-Wright rosettes (rosettes with a small  meshwork of fibers at the center)
:* Neuropil-like stroma (paucicellular stroma with a cotton candy-like appearance)
:* Neuropil-like stroma (paucicellular stroma with a cotton candy-like appearance)
* On electron microscopy neuroblastoma is characterized by:
:* Dendritic processes with longitudinally oriented microtubules
:* Membrane bound electron-dense granules that contain catecholamines
:* Presence of desmosomes
:* Absence of glycogen
* On immunohistochemistry neuroblastoma is characterized by:
:* Protein gene product (PGP) 9.5 positivity
:* Monoclonal antibody NB84 positivity
:* Synaptophysin positivity
:* CD99 marker negativity
* Neuroblastic tumors may be grouped according to International Neuroblastoma Pathology Classification (Shimada classification) into two groups: schwannian stroma rich group and a schwannian stroma poor group as illustrated below:<ref name="Stanford">Neuroblastoma, Ganglioneuroblastoma and Ganglioneuroma. Stanford Medicine Surgical Pathology Criteria(2015) http://surgpathcriteria.stanford.edu/srbc/neuroblastoma-ganglioneuroblastoma-ganglioneuroma/ Accessed on October, 5 2015</ref><ref name="pmid11745303">{{cite journal| author=Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S et al.| title=International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. | journal=Cancer | year= 2001 | volume= 92 | issue= 9 | pages= 2451-61 | pmid=11745303 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11745303  }} </ref>
<br>
{{Family tree/start}}
{{familytree  | | | | Y01 | | | | | | | | | | Y01=<div style="width: 20em; padding:0.5em;">''' Neuroblastic tumors'''</div>}}
{{familytree  | | |,|-|^|-|.| | | | | | | | }}
{{familytree  | | X01 | |  X02 | | | | | | |X01='''Schwannian stroma rich group'''| X02='''Schwannian stroma poor group'''}}
{{familytree|boxstyle= border-top: 0px;| | A01 | |  A03 | | | | | | |A01=<div style="width: 20em; padding:1em;">
'''Undifferentiated neuroblastoma'''<br>'''Poorly differentiated neuroblastoma'''<br>'''Differentiating neuroblastoma'''</div>|A03=<div style="width: 20em; padding:1em;">|A03=<div style="width: 20em; padding:1em;">
'''Nodular ganglioneuroblastoma'''<br>'''Intermixed ganglioneuroblastoma'''<br>'''Maturing ganglioneuroma'''<br>'''Mature ganglioneuroma''' </div>}}
{{Family tree/end}}
<br>
* Based on the degree of the cellular maturity and composition, neuroblastoma may be further classified into three subtypes according to the International Neuroblastoma Pathology Classification which include:<ref name="Stanford">Neuroblastoma, Ganglioneuroblastoma and Ganglioneuroma. Stanford Medicine Surgical Pathology Criteria(2015) http://surgpathcriteria.stanford.edu/srbc/neuroblastoma-ganglioneuroblastoma-ganglioneuroma/ Accessed on October, 5 2015</ref>
:* Undifferentiated neruoblastoma
:* Poorly differentiated neuroblastoma
:* Differentiating neuroblastoma
* The table below summarizes the differnces between the three histological subtypes of neurublastoma:<ref name="Stanford">Neuroblastoma, Ganglioneuroblastoma and Ganglioneuroma. Stanford Medicine Surgical Pathology Criteria(2015) http://surgpathcriteria.stanford.edu/srbc/neuroblastoma-ganglioneuroblastoma-ganglioneuroma/ Accessed on October, 5 2015</ref>
{|
! style="background: #4479BA; width: 200px; color: #FFFFFF;"|'''Risk Factor'''
! style="background: #4479BA; width: 600px; color: #FFFFFF;"|'''Description'''
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | '''Undifferentiated neruoblastoma'''|| style="padding: 5px 5px; background: #F5F5F5;" | Completely formed by neuroblasts with no maturity of ganglion cells
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | '''Poorly differentiated neuroblastoma'''|| style="padding: 5px 5px; background: #F5F5F5;" |Mostly formed by neuroblasts with less the 5% maturing ganglion cells
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | '''Differentiating neuroblastoma'''|| style="padding: 5px 5px; background: #F5F5F5;" |
Predominantly formed by neuroblasts but with more than 5% mature ganglion cells
|}
* Shown below is a series of microscopic images of different subtypes of meningioma:

Revision as of 01:19, 6 October 2015

Pathogenesis

  • Neuroblastoma arises from neural crest cells, which are normally involved in the development of the sympathetic nervous system and adrenal glands.
  • Neuroblastoma is frequently observed along the sympathetic nervous system structures. Specific sites may include:
  • Adrenal glands (35% of the cases)
  • Retroperitoneal organs (30% of the cases):
  • Organ of Zuckerkandl
  • Coeliac axis
  • Paravertebral sympathetic chain
  • Posterior mediastinum (20% of the cases)
  • Nerve tissues in the neck (1-5% of the cases)
  • Nerve tissues in the pelvis (2-3% of the cases)
  • Neuroblastoma tumor cells secrete catecholamines such as:
  • Vanillylmandelic acid (VMA)
  • Homovanillic acid (HVA)
  • Neuroblastoma may demonstrate spontaneous regression from an undifferentiated state to a completely benign cellular state.

Genetics

  • Development of neuroblasotma is the result of multiple genetic mutations.
  • The vast majority of neuroblastoma cases are sporadic.
  • 1-2% of neuroblastoma cases may demonstrate a familial predilection.
  • Genes involved in the pathogenesis of neuroblastoma include:
  • NBPF10 gene chromosome 1
  • KIF1B gene on chromosome 1
  • ALK gene on chromosome 2
  • LMO1 gene on chromosome 11
  • PHOX2A gene on chromosome 11
  • MYCN oncogene amplification is a common finding among neuroblastoma patients.

Associated Conditions

  • Neuroblastoma is associated with a number of syndromes that include:
  • Neurofibromatosis type 1 syndrome (von Recklinghausen disease)
  • Beckwith-Wiedemann syndrome
  • DiGeorge syndrome
  • Hirschsprung disease

Gross Pathology

  • On gross pathology, a well defined, bulky, and tan colored mass is a characteristic finding of neuroblastoma.
  • Other associated findings of neuroblastoma on gross pathology may include:
  • Fibrous pseudocapsule
  • Necrosis
  • Hemorrhage
  • Calcification

Microscopic Pathology

  • On microscopic histopathological analysis the presence of round blue cells separated by thin fibrous septa are characteristic findings of neuroblastoma.
  • Other findings of neuroblastoma on light microscopy may include:
  • Homer-Wright rosettes (rosettes with a small meshwork of fibers at the center)
  • Neuropil-like stroma (paucicellular stroma with a cotton candy-like appearance)
  • On electron microscopy neuroblastoma is characterized by:
  • Dendritic processes with longitudinally oriented microtubules
  • Membrane bound electron-dense granules that contain catecholamines
  • Presence of desmosomes
  • Absence of glycogen
  • On immunohistochemistry neuroblastoma is characterized by:
  • Protein gene product (PGP) 9.5 positivity
  • Monoclonal antibody NB84 positivity
  • Synaptophysin positivity
  • CD99 marker negativity
  • Neuroblastic tumors may be grouped according to International Neuroblastoma Pathology Classification (Shimada classification) into two groups: schwannian stroma rich group and a schwannian stroma poor group as illustrated below:[1][2]


 
 
 
Neuroblastic tumors
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Schwannian stroma rich group
 
Schwannian stroma poor group
 
 
 
 
 
 
 
Undifferentiated neuroblastoma
Poorly differentiated neuroblastoma
Differentiating neuroblastoma
 
Nodular ganglioneuroblastoma
Intermixed ganglioneuroblastoma
Maturing ganglioneuroma
Mature ganglioneuroma
 
 
 
 
 
 


  • Based on the degree of the cellular maturity and composition, neuroblastoma may be further classified into three subtypes according to the International Neuroblastoma Pathology Classification which include:[1]
  • Undifferentiated neruoblastoma
  • Poorly differentiated neuroblastoma
  • Differentiating neuroblastoma
  • The table below summarizes the differnces between the three histological subtypes of neurublastoma:[1]
Risk Factor Description
Undifferentiated neruoblastoma Completely formed by neuroblasts with no maturity of ganglion cells
Poorly differentiated neuroblastoma Mostly formed by neuroblasts with less the 5% maturing ganglion cells
Differentiating neuroblastoma

Predominantly formed by neuroblasts but with more than 5% mature ganglion cells


  • Shown below is a series of microscopic images of different subtypes of meningioma:
  1. 1.0 1.1 1.2 Neuroblastoma, Ganglioneuroblastoma and Ganglioneuroma. Stanford Medicine Surgical Pathology Criteria(2015) http://surgpathcriteria.stanford.edu/srbc/neuroblastoma-ganglioneuroblastoma-ganglioneuroma/ Accessed on October, 5 2015
  2. Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S; et al. (2001). "International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group". Cancer. 92 (9): 2451–61. PMID 11745303.